United States · FDA National Drug Code directory
Etodolac
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51672-4053_569a0d2d-5081-3588-e063-6394a90ad5a7
- Product NDC
- 51672-4053
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Etodolac
- Labeler
- TaSun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20030313
- Source listing expiry
- 20271231
Source-listed ingredients
- ETODOLAC — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4053-1) · 51672-4053-1
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4053-2) · 51672-4053-2
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4053-3) · 51672-4053-3
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4053-4) · 51672-4053-4
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4053-6) · 51672-4053-6
- 10 BLISTER PACK in 1 CARTON (51672-4053-9) / 6 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 51672-4053-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →